Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can Circulating Cardiac Biomarkers Be Helpful in the Assessment of LMNA Mutation Carriers?

12 May 2020

Abstract excerpt

Mutations in the lamin A/C gene are variably phenotypically expressed; however, it is unclear whether circulating cardiac biomarkers are helpful in the detection and risk assessment of cardiolaminopathies. We sought to assess (1) clinical characteristics including serum biomarkers: high sensitivity troponin T (hsTnT) and N-terminal prohormone brain natriuretic peptide (NT-proBNP) in clinically stable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy and Myosin Studies
Share to Cellular transport and secretion
Share to Nuclear Structure and Function

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32408651
DOI: 10.3390/jcm9051443

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can Circulating Cardiac Biomarkers Be Helpful in the Assessment of LMNA Mutation Carriers?PMID 32408651Read ↗

Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.Semantic proximity Read ↗

Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers.Semantic proximity Read ↗

Long-term outcome and risk stratification in dilated cardiolaminopathies.Semantic proximity Read ↗

Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation.Semantic proximity Read ↗

LMNA Cardiomyopathy: Important Considerations for the Heart Failure Clinician.Semantic proximity Read ↗

External Validation of Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation CarriersSemantic proximity Read ↗

Lamin A/C cardiomyopathy presenting as high-grade atrioventricular (AV) block, atrial fibrillation, heart failure and ventricular tachycardia in a single-family cluster.Semantic proximity Read ↗

Clinical disease presentation and ECG characteristics of LMNA mutation carriersSemantic proximity Read ↗

Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers.Semantic proximity Read ↗

Pro‐inflammatory cytokines as emerging molecular determinants in cardiolaminopathiesSemantic proximity Read ↗

What Should the Cardiologist know about Lamin Disease?Semantic proximity Read ↗

Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.